These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3801724)

  • 21. Biosynthesis of paf-acether. X. Phorbol myristate acetate-induced paf-acether biosynthesis and acetyltransferase activation in human neutrophils.
    Leyravaud S; Bossant MJ; Joly F; Bessou G; Benveniste J; Ninio E
    J Immunol; 1989 Jul; 143(1):245-9. PubMed ID: 2732470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis of paf-acether by E. coli K12].
    Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
    C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cellular retention of paf-acether by extracellular pH and cell concentration.
    Leyravaud S; Benveniste J
    Biochim Biophys Acta; 1989 Sep; 1005(2):192-5. PubMed ID: 2775773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin eosinophilia in atopic patients.
    Henocq E; Vargaftig BB
    J Allergy Clin Immunol; 1988 Apr; 81(4):691-5. PubMed ID: 3281998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Digital arteritis, thrombosis and hypereosinophilic syndrome: an uncommon complication].
    Hachulla E; Hatron PY; Janin A; Robert Y; Devulder B
    Rev Med Interne; 1995; 16(6):434-6. PubMed ID: 7652225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic synthesis of structural analogs of PAF-acether by phospholipase D-catalysed transphosphatidylation.
    Testet-Lamant V; Archaimbault B; Durand J; Rigaud M
    Biochim Biophys Acta; 1992 Feb; 1123(3):347-50. PubMed ID: 1536875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Charcot-Leyden crystals in the hypereosinophilic syndrome.
    Dincsoy HP; Burton TJ; van der Bel-Kahn JM
    Am J Clin Pathol; 1981 Feb; 75(2):236-43. PubMed ID: 6162378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of PAF-acether and precursors during allergic cutaneous reactions.
    Michel L; Denizot Y; Thomas Y; Benveniste J; Dubertret L
    Lancet; 1988 Aug; 2(8607):404. PubMed ID: 2899817
    [No Abstract]   [Full Text] [Related]  

  • 29. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.
    Henocq E; Vargaftig BB
    Lancet; 1986 Jun; 1(8494):1378-9. PubMed ID: 2872485
    [No Abstract]   [Full Text] [Related]  

  • 30. [Visceral lesions in hypereosinophilia].
    Prin L; Blétry O; Tonnel AB; Gruart V; Bodemer C; Capron M; Guillevin L; Godeau P; Capron A
    Presse Med; 1987 May; 16(19):945-9. PubMed ID: 2954143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypereosinophilic syndrome in a HIV I+ patient].
    Wattiaux MJ; Khalife J; Prin L; Giral P; Lebas J; Cabane J; Picard O; Imbert JC
    Rev Med Interne; 1989; 10(3):249-52. PubMed ID: 2762675
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversible dementia with idiopathic hypereosinophilic syndrome.
    Kaplan PW; Waterbury L; Kawas C; Bolla-Wilson K; Durack D
    Neurology; 1989 Oct; 39(10):1388-91. PubMed ID: 2797461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Hissing snake' left ventricle thrombotic phase of hypereosinophilic endomyocardial disease.
    Pieroni M; Chimenti C; Frustaci A
    Eur Heart J; 2006 Apr; 27(7):778. PubMed ID: 16540479
    [No Abstract]   [Full Text] [Related]  

  • 34. Ring eosinophils in hypereosinophilic syndrome.
    Rani S; Gautam P; Prakash S; Singh T
    Br J Haematol; 1992 May; 81(1):132-3. PubMed ID: 1520614
    [No Abstract]   [Full Text] [Related]  

  • 35. The idiopathic hypereosinophilic syndrome.
    Alfaham MA; Ferguson SD; Sihra B; Davies J
    Arch Dis Child; 1987 Jun; 62(6):601-13. PubMed ID: 3619478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of soluble interleukin-2 receptor in the serum of 30 patients with idiopathic hypereosinophilic syndrome.
    Prin L; Ameisen JC; Plumas J; Gruart V; Loiseau S; Bletry O; Fenaux P; Capron M; Capron A
    Br J Haematol; 1990 Feb; 74(2):233-4. PubMed ID: 2317461
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-alpha for the hypereosinophilic syndrome.
    Zielinski RM; Lawrence WD
    Ann Intern Med; 1990 Nov; 113(9):716-8. PubMed ID: 2088325
    [No Abstract]   [Full Text] [Related]  

  • 38. Normal plasma levels of B12 binding proteins in hypereosinophilic syndrome and secondary hypereosinophilia.
    Ghosh K; Shome DK; Marwaha N; Mohanty D; Das KC
    Blood; 1985 Feb; 65(2):510-1. PubMed ID: 3967095
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased levels of eosinophil-derived PAF-acether activity in a patient with idiopathic hypereosinophilic syndrome.
    Chamone DF; Fujimura AY; Jamra M
    Braz J Med Biol Res; 1986; 19(1):135-6. PubMed ID: 3801724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.